Primary  ||| S:0 E:8 ||| JJ
prevention  ||| S:8 E:19 ||| NN
trials  ||| S:19 E:26 ||| NNS
performed  ||| S:26 E:36 ||| VBN
with  ||| S:36 E:41 ||| IN
statins  ||| S:41 E:49 ||| JJ
prior  ||| S:49 E:55 ||| JJ
to  ||| S:55 E:58 ||| TO
the  ||| S:58 E:62 ||| DT
JUPITER  ||| S:62 E:70 ||| NNP
trial  ||| S:70 E:76 ||| NN
The  ||| S:76 E:80 ||| DT
invention  ||| S:80 E:90 ||| NN
of  ||| S:90 E:93 ||| IN
3-hydroxy-3-methylglutaryl  ||| S:93 E:120 ||| NNP
coenzyme  ||| S:120 E:129 ||| VBD
A  ||| S:129 E:131 ||| DT
( ||| S:131 E:132 ||| -LRB-
HMG-CoA ||| S:132 E:139 ||| NNP
)  ||| S:139 E:141 ||| -RRB-
reductase  ||| S:141 E:151 ||| JJ
inhibitors ||| S:151 E:161 ||| NN
,  ||| S:161 E:163 ||| ,
namely  ||| S:163 E:170 ||| RB
statins ||| S:170 E:177 ||| JJ
,  ||| S:177 E:179 ||| ,
after  ||| S:179 E:185 ||| IN
the  ||| S:185 E:189 ||| DT
mid-1980s ||| S:189 E:198 ||| NNS
,  ||| S:198 E:200 ||| ,
initiated  ||| S:200 E:210 ||| VBD
a  ||| S:210 E:212 ||| DT
new  ||| S:212 E:216 ||| JJ
era  ||| S:216 E:220 ||| NN
in  ||| S:220 E:223 ||| IN
the  ||| S:223 E:227 ||| DT
approach  ||| S:227 E:236 ||| NN
to  ||| S:236 E:239 ||| TO
atherosclerotic  ||| S:239 E:255 ||| VB
diseases ||| S:255 E:263 ||| NNS
.  ||| S:263 E:265 ||| .
Many  ||| S:265 E:270 ||| JJ
studies  ||| S:270 E:278 ||| NNS
of  ||| S:278 E:281 ||| IN
primary  ||| S:281 E:289 ||| JJ
prevention ||| S:289 E:299 ||| NN
,  ||| S:299 E:301 ||| ,
secondary  ||| S:301 E:311 ||| JJ
prevention ||| S:311 E:321 ||| NN
,  ||| S:321 E:323 ||| ,
and  ||| S:323 E:327 ||| CC
plaque  ||| S:327 E:334 ||| JJ
regression  ||| S:334 E:345 ||| NNS
have  ||| S:345 E:350 ||| VBP
been  ||| S:350 E:355 ||| VBN
carried  ||| S:355 E:363 ||| VBN
out  ||| S:363 E:367 ||| RP
with  ||| S:367 E:372 ||| IN
statins ||| S:372 E:379 ||| NN
.  ||| S:379 E:381 ||| .
This  ||| S:381 E:386 ||| DT
paper  ||| S:386 E:392 ||| NN
will  ||| S:392 E:397 ||| MD
discuss  ||| S:397 E:405 ||| VB
primary  ||| S:405 E:413 ||| JJ
prevention  ||| S:413 E:424 ||| NN
studies  ||| S:424 E:432 ||| NNS
that  ||| S:432 E:437 ||| WDT
were  ||| S:437 E:442 ||| VBD
performed  ||| S:442 E:452 ||| VBN
with  ||| S:452 E:457 ||| IN
statins  ||| S:457 E:465 ||| JJ
prior  ||| S:465 E:471 ||| JJ
to  ||| S:471 E:474 ||| TO
the  ||| S:474 E:478 ||| DT
JUPITER  ||| S:478 E:486 ||| NNP
trial ||| S:486 E:491 ||| NN
.  ||| S:491 E:493 ||| .
